SYR-472 Open-label Study
This study has been completed.
Information provided by (Responsible Party):
First received: December 13, 2012
Last updated: November 5, 2013
Last verified: November 2013
To evaluate the efficacy and safety of treatment with SYR-472 in diabetic patients.
|Study Design:||Primary Purpose: Treatment|
Resource links provided by NLM:
Further study details as provided by Takeda:
Primary Outcome Measures:
- Blood Glucose [ Time Frame: 7 days ] [ Designated as safety issue: No ]Blood Glucose
|Study Start Date:||April 2013|
|Study Completion Date:||August 2013|
|Primary Completion Date:||August 2013 (Final data collection date for primary outcome measure)|
Contacts and Locations